Human Gene PKN2 (uc010osq.2)
  Description: Homo sapiens protein kinase N2 (PKN2), mRNA.
Transcript (Including UTRs)
   Position: hg19 chr1:89,149,922-89,301,938 Size: 152,017 Total Exon Count: 21 Strand: +
Coding Region
   Position: hg19 chr1:89,226,027-89,299,131 Size: 73,105 Coding Exon Count: 20 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:89,149,922-89,301,938)mRNA (may differ from genome)Protein (827 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblExonPrimerGeneCardsGeneNetwork
HGNCHPRDLynxMGIneXtProtPubMed
ReactomeTreefamUniProtKBWikipedia

-  Comments and Description Text from UniProtKB
  ID: PKN2_HUMAN
DESCRIPTION: RecName: Full=Serine/threonine-protein kinase N2; EC=2.7.11.13; AltName: Full=PKN gamma; AltName: Full=Protein kinase C-like 2; AltName: Full=Protein-kinase C-related kinase 2;
FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c- fos serum response factor (SRF). Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication.
CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
ENZYME REGULATION: Kinase activity is activated upon binding to GTP-bound Rhoa/Rac1 GTPases. Activated by caspase-3 (CASP3) cleavage during apoptosis. Activated by lipids, particularly cardiolipin and to a lesser extent by other acidic phospholipids and unsaturated fatty acids. Two specific sites, Thr-816 (activation loop of the kinase domain) and Thr-958 (turn motif), need to be phosphorylated for its full activation.
BIOPHYSICOCHEMICAL PROPERTIES: Kinetic parameters: KM=15.83 uM for HDAC5;
SUBUNIT: Interacts (via the REM repeats) with RHOA (GTP-bound form preferentially). Interacts (via the REM repeats) with RAC1 (GTP- bound form preferentially). Interacts with NCK1 (via SH3 domains). Interacts with CD44 (By similarity). Interacts with RHOA (GTP- bound form preferentially) and RAC1 (GTP-bound form preferentially); the interactions induce its autophosphorylation. Interacts (via C-terminal kinase domain) with PDPK1; the interaction stimulates PDPK1 kinase activity. Interacts with MAP3K2; the interaction activates PRK2 kinase activity in a MAP3K2-independent kinase activity. Interacts (via C-terminus domain) with AKT1; the interaction occurs with the C-terminus cleavage product of PRK2 in apoptotic cells. Interacts (via C- terminus) with PTPN13 (via PDZ 3 domain). Interacts with HCV NS5B (via N-terminus finger domain). Interacts with NCK1, NCK2 and RHOC.
SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane (By similarity). Cell projection, lamellipodium. Cytoplasm, cytoskeleton. Cleavage furrow. Midbody. Cell junction. Note=Colocalizes with PTPN13 in lamellipodia-like structures, regions of large actin turnover. Accumulates during telophase at the cleavage furrow and concentrates finally around the midbody in cytokinesis. Recruited to nascent cell-cell contacts at the apical surface of cells. In the course of viral infection, colocalizes with HCV NS5B at perinuclear region in the cytoplasm.
TISSUE SPECIFICITY: Ubiquitous. Expressed in numerous tumor cell lines, especially in bladder tumor cells.
INDUCTION: Up-regulated during keratinocyte differentiation.
DOMAIN: The N-terminus region interferes with the interaction between AKT1 and the C-terminus region of PKN2.
DOMAIN: The C1 domain does not bind the diacylglycerol (DAG).
DOMAIN: The apoptotic C-terminus cleavage product inhibits EGF- induced kinase activity of AKT1 phosphorylation at 'Thr-308' and 'Ser-473' sites, PDPK1 autophosphorylation and kinases PRKCD and PRKCZ phosphorylations.
PTM: Autophosphorylated. Phosphorylated during mitosis.
PTM: Activated by limited proteolysis with trypsin (By similarity). Proteolytically cleaved by caspase-3 during the induction of apoptotic cell death.
SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
SIMILARITY: Contains 1 C2 domain.
SIMILARITY: Contains 1 protein kinase domain.
SIMILARITY: Contains 3 REM (Hr1) repeats.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): PKN2
CDC HuGE Published Literature: PKN2
Positive Disease Associations: Glomerular Filtration Rate , Hip , Monocytes , Respiratory Function Tests
Related Studies:
  1. Glomerular Filtration Rate
    Shih-Jen Hwang et al. BMC medical genetics 2007, A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study., BMC medical genetics. [PubMed 17903292]
    Kidney function traits and TSH are associated with SNPs on the Affymetrix GeneChip Human Mapping 100K SNP set. These data will serve as a valuable resource for replication as more SNPs associated with kidney function and endocrine traits are identified.
  2. Hip
    Douglas P Kiel et al. BMC medical genetics 2007, Genome-wide association with bone mass and geometry in the Framingham Heart Study., BMC medical genetics. [PubMed 17903296]
    The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.
  3. Monocytes
    , , . [PubMed 0]
           more ... click here to view the complete list

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 13.37 RPKM in Ovary
Total median expression: 388.03 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -180.94512-0.353 Picture PostScript Text
3' UTR -651.872807-0.232 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000961 - AGC-kinase_C
IPR000008 - C2_Ca-dep
IPR008973 - C2_Ca/lipid-bd_dom_CaLB
IPR011072 - HR1_rho-bd
IPR011009 - Kinase-like_dom
IPR017892 - Pkinase_C
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR002290 - Ser/Thr_dual-sp_kinase_dom
IPR008271 - Ser/Thr_kinase_AS

Pfam Domains:
PF00069 - Protein kinase domain
PF00168 - C2 domain
PF00433 - Protein kinase C terminal domain
PF02185 - Hr1 repeat
PF07714 - Protein tyrosine kinase
PF14531 - Kinase-like

SCOP Domains:
46585 - HR1 repeat
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
56112 - Protein kinase-like (PK-like)

ModBase Predicted Comparative 3D Structure on Q16513
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
 Protein Sequence    
 Alignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0003723 RNA binding
GO:0004672 protein kinase activity
GO:0004674 protein serine/threonine kinase activity
GO:0004697 protein kinase C activity
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016740 transferase activity
GO:0017049 GTP-Rho binding
GO:0042826 histone deacetylase binding
GO:0045296 cadherin binding
GO:0070063 RNA polymerase binding

Biological Process:
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006468 protein phosphorylation
GO:0006915 apoptotic process
GO:0007049 cell cycle
GO:0007155 cell adhesion
GO:0007165 signal transduction
GO:0010631 epithelial cell migration
GO:0016310 phosphorylation
GO:0018105 peptidyl-serine phosphorylation
GO:0030030 cell projection organization
GO:0032467 positive regulation of cytokinesis
GO:0035556 intracellular signal transduction
GO:0043297 apical junction assembly
GO:0045070 positive regulation of viral genome replication
GO:0045931 positive regulation of mitotic cell cycle
GO:0051301 cell division
GO:2000145 regulation of cell motility

Cellular Component:
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005813 centrosome
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0016604 nuclear body
GO:0030027 lamellipodium
GO:0030054 cell junction
GO:0030496 midbody
GO:0032154 cleavage furrow
GO:0032991 macromolecular complex
GO:0042995 cell projection
GO:0043296 apical junction complex
GO:0045111 intermediate filament cytoskeleton
GO:0048471 perinuclear region of cytoplasm


-  Descriptions from all associated GenBank mRNAs
  AK300304 - Homo sapiens cDNA FLJ61394 complete cds, highly similar to Serine/threonine-protein kinase N2 (EC 2.7.11.13).
AK298595 - Homo sapiens cDNA FLJ52349 complete cds, highly similar to Serine/threonine-protein kinase N2 (EC 2.7.11.13).
AF118089 - Homo sapiens PRO2042 mRNA, complete cds.
BC125199 - Homo sapiens protein kinase N2, mRNA (cDNA clone MGC:150606 IMAGE:40123309), complete cds.
S75548 - protein kinase PRK2 [human, DX3 B-cell myeloma cell line, mRNA, 3255 nt].
U33052 - Human lipid-activated, protein kinase PRK2 mRNA, complete cds.
AB527857 - Synthetic construct DNA, clone: pF1KB8545, Homo sapiens PKN2 gene for protein kinase N2, without stop codon, in Flexi system.
KJ905869 - Synthetic construct Homo sapiens clone ccsbBroadEn_15539 PKN2 gene, encodes complete protein.
AK301066 - Homo sapiens cDNA FLJ50881 complete cds, highly similar to Serine/threonine-protein kinase N2 (EC 2.7.11.13).
BC062620 - Homo sapiens protein kinase N2, mRNA (cDNA clone IMAGE:5198993), complete cds.
KJ905868 - Synthetic construct Homo sapiens clone ccsbBroadEn_15538 PKN2 gene, encodes complete protein.
JD185121 - Sequence 166145 from Patent EP1572962.
AK023692 - Homo sapiens cDNA FLJ13630 fis, clone PLACE1011057.
JD434313 - Sequence 415337 from Patent EP1572962.
JD355299 - Sequence 336323 from Patent EP1572962.
BC029749 - Homo sapiens protein kinase N2, mRNA (cDNA clone IMAGE:4513287), partial cds.
BC038832 - Homo sapiens, clone IMAGE:3918621, mRNA.
BC006993 - Homo sapiens cDNA clone IMAGE:3995912.
BC046146 - Homo sapiens, clone IMAGE:4443164, mRNA.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q16513 (Reactome details) participates in the following event(s):

R-HSA-5623622 RHOA, RHOB, RHOC and RAC1 bind PKN1, PKN2 or PKN3
R-HSA-5623667 PDPK1 phosphorylates PKN1,2,3
R-HSA-5623632 RHOA,RHOB,RHOC,RAC1:GTP:PKN1,2,3 binds PDPK1:PIP3
R-HSA-5625740 RHO GTPases activate PKNs
R-HSA-195258 RHO GTPase Effectors
R-HSA-194315 Signaling by Rho GTPases
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: AK298595, B4DQ21, B4DTP5, B4DVG1, D3DT24, PKN2_HUMAN, PRK2, PRKCL2, Q08AF4, Q16513, Q9H1W4
UCSC ID: uc010osq.2
RefSeq Accession: NM_006256
Protein: Q16513 (aka PKN2_HUMAN)

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: AK298595.1
exon count: 21CDS single in 3' UTR: no RNA size: 3152
ORF size: 2484CDS single in intron: no Alignment % ID: 99.94
txCdsPredict score: 3555.00frame shift in genome: no % Coverage: 99.84
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.